A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

Key facts

Sponsor

David M. Simpson

Principal Investigator

David M Simpson, MD, MD

Icahn School of Medicine at Mount Sinai

Intervention

Abobotulinum toxin A(drug)

Enrollment

25 target

Eligibility

18-80 years · All sexes

Timeline

2018 – 2022

Study locations (1)

• Icahn School of Medicine at Mount Sinai, New York, New York, United States

Collaborators

Ipsen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07449091
  Adaptability of an Undetectable = Untransmissible Model for HBV
  NYU Langone Health
• RECRUITINGNCT07577492
  Cervical Position Sense, Core Stability, and Postural Balance in University Students With Upper Crossed Syndrome
  Istinye University
• RECRUITINGNANCT07588061
  Comparative Effect of Maitland Mobilization Combined With Kendall Exercises for Pain and Postural Alignment in Adults With Upper Cross Syndrome
  Ibadat International University, Islamabad
• RECRUITINGNANCT07496853
  Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke
  Ankara Yildirim Beyazıt University
• RECRUITINGNCT07426718
  A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.
  Portsmouth Hospitals NHS Trust
• RECRUITINGNCT07401732
  Dysphagia in Rheumatoid Arthritis
  Tanta University
• RECRUITINGNANCT07578831
  Comparative Effects of Kendall and Feldenkrais Exercise in Upper Crossed Syndrome
  Riphah International University
• ACTIVE NOT RECRUITINGNANCT07236385
  AI Training Program vs Standard Correction for Forward Head and Rounded Shoulder in Neck Pain
  Cairo University

See all trials for Oculocerebral hypopigmentation syndrome, Cross type →